A study has found a new way to regenerate insulin-producing cells to treat diabetes in the form of MNK2 protein. The MNK2 protein could serve as a source of insulin for both type 1 and type 2 diabetes.
A novel possible treatment target for diabetes has been identified by a Swedish researcher. In zebrafish larvae, laboratory pigs, and human cell cultures, inhibition of the protein MNK2 led to the regeneration of pancreatic insulin-producing cells.
According to Dr. Olov Andersson, senior researcher at the Department of Cell and Molecular Biology at the Karolinska Institute, "our findings indicate a new potential target for treating diabetes, in that we demonstrate a possible way of stimulating the formation of new insulin-producing cells."
According to the study (read below), regeneration of insulin-producing beta cells in the pancreas occurred when the MNK2 protein was completely removed or inhibited in zebrafish cells.
Insulin is produced by beta cells, which are found...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
